(Gateway Pundit) For almost three years, The Gateway Pundit has been reporting about the efficacy of Ivermectin and HCQ in treating COVID-19.
There have now been 90 Ivermectin COVID-19 controlled studies from 963 scientists in 27 countries that show an 83%, 62%, and 39% improvement for prophylaxis, early, and late treatment respectively in COVID patients.
“178 ivermectin COVID-19 studies, 127 peer-reviewed, 90 comparing treatment and control groups. Ivermectin has been officially adopted for early treatment in all or part of 22 countries (38 including non-government medical organizations),” according to the COVID-19 treatment studies tracker website.
On Saturday, Rep. Marjorie Taylor Greene (GA-R) responded to a tweet by former UFC/MMA fighter Jake Shields about an Ivermectin study used on 88,012 people with a 92% reduction in death. This study was published on the NIH website.
The study used 88,012 people with 92% reduction in death
This isn’t minor this is massive Decline in deaths pic.twitter.com/i8BIXhW5pa
— Jake Shields (@jakeshieldsajj) September 1, 2022
The Gateway Pundit reported a similar study early this year in Brazil. You can read it here.
A citywide prevention program using ivermectin as prophylaxis for COVID-19 was implemented in Itajaí, a southern city in Brazil in the state of Santa Catarina between July 2020 and December 2020.
In early July, the city mayor of Itajaí, Dr. Volnei José Morastoni announced a citywide use of Ivermectin against COVID-19. The mayor distributed Ivermectin kits totaling 1.5 million tablets to the residents of Itajaí. The study of this program was published on NIH website.
According to this comprehensive study, the regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and death rates. The ivermectin non-users were two times more likely to die of COVID-19 than ivermectin users in the overall population analysis.
Below is an excerpt from Rep. Greene’s Twitter timeline:
